These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 20451416

  • 1. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy.
    Wheat JC, Weizer AZ, Wolf JS, Lotan Y, Remzi M, Margulis V, Wood CG, Montorsi F, Roscigno M, Kikuchi E, Zigeuner R, Langner C, Bolenz C, Koppie TM, Raman JD, Fernández M, Karakiewizc P, Capitanio U, Bensalah K, Patard JJ, Shariat SF.
    Urol Oncol; 2012; 30(3):252-8. PubMed ID: 20451416
    [Abstract] [Full Text] [Related]

  • 2. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [Abstract] [Full Text] [Related]

  • 3. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 5. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
    Chromecki TF, Cha EK, Fajkovic H, Margulis V, Novara G, Scherr DS, Lotan Y, Raman JD, Kassouf W, Bensalah K, Weizer A, Kikuchi E, Roscigno M, Remzi M, Matsumoto K, Walton TJ, Pycha A, Ficarra V, Karakiewicz PI, Zigeuner R, Pummer K, Shariat SF.
    Eur Urol; 2012 Feb; 61(2):245-53. PubMed ID: 21975249
    [Abstract] [Full Text] [Related]

  • 6. Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
    Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF.
    Urol Int; 2011 Feb; 87(1):42-8. PubMed ID: 21659717
    [Abstract] [Full Text] [Related]

  • 7. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M, French Collaborative National Database on UUT-UC.
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [Abstract] [Full Text] [Related]

  • 8. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.
    Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Raman JD, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Fernández MI, Ströbel P, Wheat J, Zigeuner R, Langner C, Waldert M, Oya M, Guo CC, Ng C, Montorsi F, Wood CG, Margulis V, Karakiewicz PI.
    Eur Urol; 2009 Jul; 56(1):1-9. PubMed ID: 19361911
    [Abstract] [Full Text] [Related]

  • 9. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF, Palapattu GS, Karakiewicz PI, Rogers CG, Vazina A, Bastian PJ, Schoenberg MP, Lerner SP, Sagalowsky AI, Lotan Y.
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [Abstract] [Full Text] [Related]

  • 10. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS, Badalato GM, Hruby GW, Razmjoo M, McKiernan JM.
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
    Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration.
    Cancer; 2009 Mar 15; 115(6):1224-33. PubMed ID: 19156917
    [Abstract] [Full Text] [Related]

  • 12. Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF, Bladder Cancer Research Consortium (BCRC), Upper Tract Urothelial Carcinoma Collaboration (UTUCC).
    Eur Urol; 2012 Oct 15; 62(4):677-84. PubMed ID: 22349570
    [Abstract] [Full Text] [Related]

  • 13. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort.
    Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF.
    BJU Int; 2011 Aug 15; 108(3):406-12. PubMed ID: 21078048
    [Abstract] [Full Text] [Related]

  • 14. Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients.
    Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G.
    World J Urol; 2011 Aug 15; 29(4):487-94. PubMed ID: 21249372
    [Abstract] [Full Text] [Related]

  • 15. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
    Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD.
    Urol Oncol; 2013 Aug 15; 31(6):904-8. PubMed ID: 21906967
    [Abstract] [Full Text] [Related]

  • 16. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, Upper Tract Urothelial Carcinoma Collaboration.
    Eur Urol; 2014 Jan 15; 65(1):210-7. PubMed ID: 22579047
    [Abstract] [Full Text] [Related]

  • 17. Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tract.
    Yuasa T, Tsuchiya N, Narita S, Inoue T, Saito M, Kumazawa T, Horikawa Y, Matsuura S, Satoh S, Nanjo H, Habuchi T.
    Urology; 2006 Nov 15; 68(5):972-5. PubMed ID: 17095072
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
    Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, Asano T.
    Urol Int; 2012 Nov 15; 88(2):225-31. PubMed ID: 22236640
    [Abstract] [Full Text] [Related]

  • 19. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM, Bagrodia A, Lotan Y, Gayed BA, Darwish OM, Youssef RF, John G, Harrow B, Jacobs C, Gaitonde M, Sagalowsky AI, Shariat SF, Kapur P, Margulis V.
    J Urol; 2014 Jan 15; 191(1):28-34. PubMed ID: 23871758
    [Abstract] [Full Text] [Related]

  • 20. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y, Turun S, Qiang W, Junhao L, Haichao Y, Shengqiang Q, Ping H, Dehong C.
    Urol Oncol; 2015 May 15; 33(5):204.e9-16. PubMed ID: 25800374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.